Evidence map›Paper›PMID 41904468›Full record

ArticleJournal of biological engineering2026

Pathway reconstruction of Corynebacterium glutamicum for C30 carotenoid 4,4'-diaponeurosporene production.

Chi Young Hwang, Eui-Sang Cho, Seong-Bo Kim, Myung-Ji Seo

Abstract read
In one paragraph

Article in Journal of biological engineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Chi Young Hwang *Department of Bioengineering and Nano-Bioengineering, Incheon National University, Incheon, 22012, Republic of Korea.
Eui-Sang Cho *Division of Bioresources Bank, Honam National Institute of Biological Resources, Mokpo, 58762, Republic of Korea.
Seong-Bo KimBio-Living Engineering Major, Global Leaders College, Yonsei University, Seoul, 03722, Republic of Korea.
Myung-Ji SeoDepartment of Bioengineering and Nano-Bioengineering, Incheon National University, Incheon, 22012, Republic of Korea. mjseo@inu.ac.kr.

Funding

National Research Foundation of Korea RS-2022-NR072558National Research Foundation of Korea RS-2024-00406342
6 · The paper itself

Abstract

4,4′-Diaponeurosporene (4,4′-DIA) is a rare C30 carotenoid with strong antioxidant and immune-enhancing properties. However, microbial production of 4,4′-DIA has been limited by low titers and the simultaneous formation of undesired carotenoid byproducts. In this study, Corynebacterium glutamicum was rationally engineered to enable selective 4,4′-DIA biosynthesis through pathway reconstruction. To redirect metabolic flux toward C30 carotenoids, the native C50 carotenoid biosynthetic gene cluster was deleted and the precursor supply was reconfigured by replacing the core C20 derivative pathway with ispA to produce C15 precursor. A gene module enabling high-level and selective production of 4,4′-DIA was established through the combinatorial expression of crtM and crtN in a constitutive vector system. Pathway analysis predicted crtN to be a bottleneck in 4,4′-DIA biosynthesis, and its expression was strengthened through promoter introduction, leading to improved production level. Deletion of poxB and ldhA combined with ribK overexpression enhanced both 4,4′-DIA biosynthetic gene expression and production, likely due to improvement carbon flux and cofactor supply. The final engineered strain was successfully transferred to a 5-L fed-batch fermentation with a 4,4′-DIA titer of 656.3 mg/L without any inducer. This work demonstrates the selective production of the rare and non-commercial C30 carotenoid 4,4′-DIA in C. glutamicum, establishing it as a robust platform for diversified carotenoid biosynthesis.

Indexed as

4,4′-diaponeurosporeneC30 carotenoidCombinatorial biosynthesisMetabolic engineeringMicrobial production

Identifiers

PMID41904468
PMCPMC13151236

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.